bradykinin B2 receptor antagonist – Prof. Marcus Maurer

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals

212

Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals Read More »

Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study

173

Bas, M.+, Greve, J., Hoffmann, T., Reshef, A., Aberer, W., Maurer, M. Kivity, S., Farkas, H., Floccard, B., Arcoleo, F., Martin, L., Sitkauskiene, B., Bouillet, L., Schmid-Grendelmeier, P., Li, H., and Zanichelli, A.: Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study. Allergy 2013: 68; 1452-1459. IF: 5.99